David Risinger
David Risinger is an analyst at Leerink Partners, focusing on the healthcare sector. He provided commentary on Johnson & Johnson's financial performance, noting the company's cautious approach in maintaining its earnings forecast amidst stock market volatility and the looming threat of tariffs. Risinger's analysis highlights the resilience of J&J in navigating a challenging economic landscape.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Ireland | 1 | 8.00 | 0.04% | +0% | 5,030,000 | 2,067 | $5,100 | 2$ |
| Totals | 1 | 5,030,000 | 2,067 | $5,100 | 2$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
David Risinger, a Leerink analyst, wrote that J&J’s decision not to slash its forecast is a welcome relief in the wake of recent stock market turmoil.
8